Zepbound (tirzepatide) is a relatively new glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) weekly subcutaneous prescription medication for people with obesity or overweight
We used the search terms fracture, osteoporosis, semaglutide, calorie restriction, bariatric surgery, bone density, bone turnover markers, liraglutide, tirzepatide, Glucagon-like peptide 1, and glucagon-like peptide receptor analogues in combination with the terms obesity and diabetes
Effects of sleeve gastrectomy and ileal transposition, alone and in combination, on food intake, body weight, gut hormones, and glucose metabolism in rats
Below is a framework comparing alcohol types and their relative risks when combined with semaglutide or tirzepatide treatment